MAYA TEAM

Robin Carhart-Harris

Scientific Director
LinkedIn Icon
Team member image

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomized controlled trial comparing psilocybin with the SSRI, escitalopram, for depression, published in the New England Journal of Medicine, and a multimodal imaging study in first time users of psilocybin. Robin has published over 100 scientific papers. He founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind. In 2021, he was listed in TIME magazine’s ‘100 Next’, a list of 100 rising stars shaping the future. Also in 2021, he moved to University of California, San Francisco, becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry. At UCSF, Robin will serve as Director of the new Psychedelics Division within the translational neuroscience Centre, Neuroscape.

Meet more of the team

Prachi Nagpal

Senior QA Engineer
View Bio

Bona Lee

Associate Product Manager
View Bio

Nick Fray

Senior Software Engineer
View Bio

Hannes Kettner

Research Manager
View Bio

Robin Carhart-Harris

Scientific Director

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomized controlled trial comparing psilocybin with the SSRI, escitalopram, for depression, published in the New England Journal of Medicine, and a multimodal imaging study in first time users of psilocybin. Robin has published over 100 scientific papers. He founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind. In 2021, he was listed in TIME magazine’s ‘100 Next’, a list of 100 rising stars shaping the future. Also in 2021, he moved to University of California, San Francisco, becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry. At UCSF, Robin will serve as Director of the new Psychedelics Division within the translational neuroscience Centre, Neuroscape.

Back to About Us

Based in Denver, Colorado.

Meet more of the team.

David Champion

CEO & Founder
View Bio

Alex Edwards

VP Product
View Bio

Eamon Armstrong

Community Liaison
View Bio

Hannes Kettner

Research Manager
View Bio